|
Introduction:
The persistent inability to achieve a penile erection
of sufficient rigidity and duration to allow satisfactory
sexual activity is a common and most distressing abnormality
of male sexual function. Its successful treatment
results in significant improvements in many aspects
of quality of life for both the patient and his partner.
Erection occurs as a result of local genital or central
sexual stimulation. In the penis cyclic guanosine
monophosphate (GMP) is produced, resulting in relaxation
of the corporal smooth muscle and influx of blood
into the sinusoids. The rapid inflow of blood obstructs
the venous outflow causing engorgement of the penis
and an erection. The nerve pathways involved include
non- adrenergic non-cholinergic and parasympathetic
systems with nitric oxide, Prostaglandin E1, vasoactive
intestinal polypeptide and, to a lesser extent, acetylcholine
as implicated neurotransmitters.
Etiology:
Although there is a direct relationship
between aging and erectile dysfunction, it is not
necessarily a consequence of age as young men with
organic disease can also suffer from it.
In 80 % of affected men the cause is found to be predominantly
organic. Many will also have a psychosexual element
to their problem which is usually unrecognized and
untreated, leading to long-term failure of many therapies
which are aimed purely at achieving an erection.
The common organic causes include:
- Diabetes
mellitus, especially patients with vascular
or neuropathic complications.
- Generalized
vascular disease.
- Hypertension
and drugs used to control it.
- Neurological
disorders e.g. multiple sclerosis and spinal
injury.
- Trauma
causing nerve or vascular damage (fractured
pelvis, radial prostatectomy,abdominoperineal
resection) and Hypogonadism
|
| A
number of drugs can also cause male erectile dysfunction |
- Central
nervous system drugs like (tricyclic antidepressants,
monoamine oxidase inhibitors, Phenothiazines,
Benzediazepimes and Butyrophenones).
- Antihypertensive
drugs (Diuretics).
- Others
(Cimetidine, Finasteride, Oestrogens Antiandrogens).
|
|
Assessment:
This is aimed at screening for disorder
associated with erectile dysfunction, and the
rare conditions for which specific treatments
are available. Blood pressure should be checked
and the urine tested for glucose.
The presence of gynaecomastia should be sought
and local examination of the genitalia should
identify induration with plaques in the penis
and testicular size.
In men with lack of libido or those presenting
after surgery or radiotherapy to the groin or
scrotal contents, serum testosterone, sex hormone
binding globulin (SHBG) and Prolactin should
be measured.
Treatment:
The specific treatment used depends mainly
upon the choice of the patient and partner,
and can only be made after a full discussion
of the treatment options available.
|
- Systemic
therapy: 1.) Testosterone: this should only
be given to men with proven deficiency.
- Sildenafil:
This is a type 5 Phosphodiasterase inhibitor,
which, by preventing the breakdown of cyclic
(GMP), prolongs corporal smooth muscle relaxation.
It is only effective when cyclic (GMP) is
present in penile smooth muscle, its action
is increased by local or central sexual arousal.
In men with erectile dysfunction as a result
of psychogenic, organic or mixed etiologies,
Sildenafil (Viagra) 50-100 mg improved both
the quality, frequency and rigidity of erections
by about 30% that normally achieved.
|
|
Concurrent use of Viagra
with organic nitrate or nitric oxide donors
e.g., amyl nitrite (Poppers) is contraindicated,
because of the risk of severe hypotension. It
should not be given to men with conditions predisposing
to priapism e.g., Sickle cell disease or to
men with severe hepatic disturbances, hypotension,
a recent myocardial infarction or cerebrovascular
accident.
|
- Apomorphine
and Pentoxyfylline.
- Local
therapy: Muse (Alprostadil): Following insertion
in the urethra of pellet of Alprostadil, an
erection satisfactory for intercourse will
be achieved in 65% in men with organic erectile
dysfunction.
- Intracavernosal
Alprostadil (Prostaglandin E1) Injection.
But intracavernosal vasoactive intestinal
polypeptide combined with phentolamine is
awaiting licensing as intracavernosal therapy,
which is painless than (Prostaglandin E1)
(Cavarject) and particularly effective in
patients with erectile dysfunction secondary
to venous leakage.
- Mechanical
devices:Vacuum erection devices: Negative
pressure around the penis increases corporal
blood flow. The ensuing erection is maintained
by the placement of a constriction ring around
the base of the penis to decrease corporal
venous drainage.
- Penile
Prosthesis:This should be considered for those
patients, who failing to respond to less invasive
therapies or who have developed problems with
them, e.g., penile fibrosis they are suitable
for men with erectile dysfunction secondary
to Peyronie’s disease (Induration penis plastica)
and those who have developed erectile dysfunction
as a result of priapism.
- Psychological
therapy: The treatments described are aimed
at producing an erection without addressing
the social, marital and psychological problems
that many men have, either as a cause of or
as result of their erectile dysfunction.
Psychotherapy or counseling can often be effective
in bringing fears and anxieties under control
and in relieving depression.
Common problems helped by psychotherapy include
the failure to realize that the ability to
achieve an erection declines with age, unrealistic
expectations resulting from mistaken beliefs
about sexuality, an absence of manual sexual
contact, anger, resentment and hostility and
denial of sex as a part of power play.
|
| Conclusions: |
-
Male erectile dysfunction is a common disorder
associated with many diseases.
- Failure
to recognize its results in significant patient/partner
leads to disharmony and marital breakdown.
- Current
therapies available are not universally successful
in achieving an erection, nor do they deal
the marital and social problems associated
with erectile dysfunction.
- A
“holistic’ approach to treatment of the man
and his partner will produce the best long-term
results, with significant improvements in
quality of life for both partners.
|
Prof.
Dr. Semir Al Samarrai
Uro-surgeon
Future Medical Center- Dubai
Tel : 971-4-2211197
Fax: 00971-4-2213332
P.O.Box : 15376,
Al Maktoum Street,
Qatar Consulate Bldg,Doha Centre.
7th Floor . Flat No.704 - Dubai
United Arab Emirates
E-mail : Info@profsam.com |
|